Synthesis of 1-aroyl-3,5-dimethyl-1H-pyrazoles as anti-HCV and anticancer agents

Letters in Drug Design and Discovery

Volumn 11, Issue 2, 2014, Pages 121-131

  Aydin, Sevil ^a   Kaushik Basu, Neerja ^b   Özbaş Turan, Suna ^a   Akbuǧa, Jülide ^a   Tiber, Pinar Mega ^c   Orun, Oya ^c   Gurukumar, K R ^b   Basu, Amartya ^b   Küçükgüzel, Ş Güniz ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Anticancer activity; Apoptosis; Diflunisal; Hepatitis C NS5B polymerase; Microwave; Pyrazole

Indexed keywords

1 [2 (2 FLUOROBIPHENYL 4 YL)PROPANOYL] 3,5 DIMETHYL 1H PYRAZOLE; 1 [2 (6 METHOXY 2 NAPHTHYL)PROPANOYL] 3,5 DIMETHYL 1H PYRAZOLE; 1 AROYL 3,5 DIMETHYL 1H PYRAZOLE DERIVATIVE; 3 [(3,5 DIMETHYL 1H PYRAZOL 1 YL)CARBONYL] 2',4' DIFLUOROBIPHENYL 4 OL; 4 [(3,5 DIMETHYL 1H PYRAZOL 1 YL)CARBONYL]PYRIDINE; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; N [1 [(3,5 DIMETHYL 1H PYRAZOL 1 YL)CARBONYL] 3 (METHYLTHIO)PROPYL]BENZAMIDE; N [4 [(3,5 DIMETHYL 1H PYRAZOL 1 YL)CARBONYL]PHENYL]BENZAMIDE; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL STRAIN K 562; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA STRAND BREAKAGE; DRUG SCREENING; DRUG SYNTHESIS; FLOW CYTOMETRY; GENOTYPE; GREEN CHEMISTRY; HEPATITIS C; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; LEUKEMIA CELL LINE; LUNG NON SMALL CELL CANCER; MICROWAVE IRRADIATION; MTT ASSAY; MYELOID LEUKEMIA; NICK END LABELING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REPLICON; RNA REPLICATION; TUMOR CELL LINE;

EID: 84893735234     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/15701808113109990069     Document Type: Article

References (44)

1. Lv, P.C.; Li, H.Q.; Sun, J.; Zhou, Y.; Zhu, H.L. Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents. Bioorg. Med. Chem., 2010, 18, 4606-4614.
2. Leahy, K.M.; Koki, A.T.; Masferrer, J.L. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis inangiogenic endothelial cells in vivo. Cancer Res., 2002, 62, 625-631.
3. Abadi, A.H.; Eissa, A.A.; Hassan, G.S. Synthesis of novel 1,3,4- trisubstituted pyrazole derivatives and their evaluation as antitumor and antiangiogenic agents. Chem. Pharm. Bull. (Tokyo), 2003,51(7), 838-844.
4. Rostom, S.A. Polysubstituted pyrazoles, part 6. Synthesis of some1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents. Bioorg. Med. Chem., 2010, 18, 2767-2776.
5. Sharma, A.; Pathan, T.; Mohan, R.; Ramaa, C.S. Synthesis and in vitro antitumor activity of novel fluorine containing pyrazoles and pyrazolines. Lett. Drug Des. Discov., 2011, 8, 843-849.
6. Bekhit, A.A.; Ashour, H.M.; Abdel Ghany, Y.; Bekhit, Ael-D.; Baraka, A. Synthesis and biological evaluation of some thiazolyland thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents. Eur. J. Med. Chem., 2008, 43(3), 456-463.
7. Pathak, R.B., Chovita, P.T., Parekh, H.H. Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives. Bioorg. Med. Chem. Lett., 2012, 22, 5129-5133.
8. Rashad, A.E.; Hegab, M.I.; Abdel-Megeid, R.E.; Fathalla, N.; Abdel-Megeid, F.M. Synthesis and anti-HSV-1 evaluation of some pyrazoles and fused pyrazolopyrimidines. Bioorg. Med. Chem.,2008, 16, 7102-7106.
9. Secci, D.; Bolasco. A.; Chimenti, P.; Carradori, S. The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/ anticonvulsant agents. Curr. Med. Chem., 2011,18(33), 5114-5144.
10. Abdel-Aziz, M.; Abuo-Rahma, Gel-D.; Hassan, A.A. Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities. Eur. J. Med. Chem., 2009, 44, 3480-3487.
11. Okamoto, M.; Sakai, M.; Goto, Y.; Salim, M.T.; Baba, C.; Goto, K.; Watashi, K.; Shimotohno, K.; Baba, M. Anti-bovine viral diarrhea virus and hepatitis C virus activity of the cyclooxygenase inhibitor SC-560. Antivir. Chem. Chemother., 2009, 20(1), 47-54.
12. Cadman, E. C.; Dix, D. E.; Handschumacher, R. E. Clinical, biological and biochemical effects of pyrazofurin. Cancer Res. 1978, 38, 682-688.
13. Gedye, R.N.; Smith, F.E.; Westaway, K.C. The rapid synthesis of organic compounds in microwave ovens. Can. J. Chem., 1988, 66, 17-26.
14. Lidström, P.; Tierney, J.; Wathey, B.; Westman, J. Microwave assisted organic synthesis - a review. Tetrahedron, 2001, 57, 9225-9268.
15. Nüchter, M.; Ondruschka, B.; Bonrath, W.; Gum, A. Microwave assisted synthesis-a critical technology overview. Green Chem., 2004, 6, 128-141.
16. Anastas, P.T.; Kirchhoff, M.M. Origins, current status, and future challenges of green chemistry. Acc. Chem. Res., 2002, 35, 686-694.
17. Romagnoli, R.; Baraldi, P.G.; Lopez, O.C.; Carrion, M.D.; Cara, C.L.; Preti, D.; Tabrizi, M.A.; Balzarini, J. Microwave-Assisted Synthesis of Substituted 2,4-Diarylthiazoles and their Evaluation as Anticancer Agents. Lett. Drug Des. Discov., 2007, 4, 464-466.
18. Amir, M.; Kumar, S. Synthesis of some new 2-(2-fluoro-4- biphenylyl)propionic acid derivatives as potential anti-inflammatory agents. Pharmazie, 2005, 60(3), 175-180.
19. Kücücgücel, Ş.G.; Mazi, A.; Şahin, F.; Öztück, S.; Stables, J.P. Synthesis and biological activities of diflunisal hydrazide- hydrazones. Eur. J. Med. Chem., 2003, 38, 1005-1013.
20. Sharma, V.; Khan, M.S.Y. Prodrugs and mutual prodrugs: synthesis of some new pyrazolone and oxadiazole analogues of a few non-steroidal anti-inflammatory drugs. Pharmazie, 2003, 58(2), 99-103.
21. Durgun, B.B.; Rollas, S. Synthesis and characterization of some arylhydrozones of p-(benzoylamino) benzoic acid hydrazide. J. Pharm. Univ., 1991, 7, 107-111.
22. Tatar, E.; Kücücgücel, I.; De Clerc, E.; Şahin, F.; Güclüce, M. Synthesis, characterization and screening of antimicrobial, antituberculosis, antiviral and anticancer activity of novel 1,3- thiazolidine-4-ones derived from 1-[2-(benzoylamino)-4-(methyllthio) butyryl]-4-alkyl/arylalkyl thiosemicarbazides. ARKIVOC, 2008, 14, 191-210.
23. Constable, D.J.C.; Curzonsb, A.D.; Cunningham, V.L. Metrics to 'green chemistry' -which are the best? Green Chem., 2002, 4, 521-527.
24. Brokaite, K.; Mickevicius, V.; Mikulskiene, G. Synthesis and structural investigation of some 1,4-disubstituted-2-pyrrolidinones. ARK IVOC, 2006, 2, 61-67.
25. Lee, J.C.; Tseng C.K.; Chen K.J.; Huang K.J.; Lin C.K.; Lin Y.T. A cell-based reporter assay for inhibitor screening of hepatitis C virus RNA-dependent RNA polymerase. Anal. Biochem., 2010, 403, 52-62.
26. Golub, A.G.; Gurukumar, K.R.; Basu, A.; Bdzhola, V.G.; Bilokin, Y.; Yarmoluk, S.G.; Lee, J-C.; Talele, T.T.; Nichols D.B.; Kaushik-Basu, N. Discovery of New Scaffolds for Rational Design of HCV NS5B Polymerase Inhibitors. Eur. J. Med. Chem., 2012,58, 258-264.
27. Grever, M.R.; Schepartz, S.A.; Chabner, B.A. The National Cancer Institute cancer drug discovery and development program. Semin. Oncol., 1992, 19, 622-638.
28. Boyd, M.R.; Paul, K.D. Some practical consideration and applications of the NCI in vitro drug discovery screen. Drug Dev. Res., 1995, 34, 91-109.
29. Weinstein, J.N.; Myers, T.G.; O'Connor, P.M.; Friend, S.H.; Fornance, A.J.; Kohn, K.W., Fojo, T.; Bates, K.; Van Osdol, W.W.; Monks, A.P.; Scudiero, D.A.; Sausville, E.A.; Zaharevitz, D.W.; Bunow, B.; Viswanadhan, V.N.; Johnson, G.S.; Wittes, R.E.; Paull, K.D. An information-intensive approach to the molecular pharmacology of cancer. Sci., 1997, 275, 343-349.
30. Boyd, M.R. Status of the NCI Prechnical Antitumor Drug Discovery Screen. Princ. Pract. Oncol., 1989, 3(10), 1-12.
31. Monks, A.P.; Scudiero, D.A.; Shekan, P.; Shoemaker, K.D.; Paull, D.; Vistica, C.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A.; Gray-Goodrich, M.; Cambell, H.; Mayo, M.; Boyd, M. Feasibility of a high-flux anticancer drug screen utilizing a diverse panel of human tumor cell lines in culture. J. Natl. Cancer Inst., 1991,83, 757-766.
32. Mossman, T. J. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Immunol. Methods, 1983, 65, 55-63.
33. Beekman, A.C.; Barentsen, A.R.; Woerdenbag, H.J.; Uden, W.V.; Pras, N. Stereochemistry dependent cytotoxicity of some artemisinin derivatives. J. Nat. Prod., 1997, 60, 325-330.
34. Srivastava, V.; Negi, A.S.; Kumar, J.K.; Faridi, U.; Sisodia, B.S.;Darokar, M.P., Luqman, S.; Khanuja, S.P.S. Synthesis of 1- (3′,4′,5′-trimethoxy)phenyl naptho[2,1-b]furan as anovel anticancer agent. Bioorg. Med. Chem., 2006, 16, 911-914.
35. Soliman, R.; Darwish, A.S. Antidiabetic activity of some 1- substituted 3,5-dimethylpyrazoles. J. Am. Chem. Soc., 1983, 26, 1659-1663.
36. Parashar, B.; Bhardwaj, S.; Sharma, S.; Gupta, G.D.; Sharma, V.K.; Punjabi, P.B. Comparative conventional and microwave assisted synthesis of some pyrazoline derivatives and their antimicrobial activity. J. Chem. Pharm. Res., 2010, 2(3), 33-42.
37. Amir, M.; Kumar, S. Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of 3,5-dimethyl pyrazoles, 3-methyl pyrazol-5-ones and 3,5-disubstituted pyrazolines. Ind. J.Chem., 2005, 44B, 2532-2537.
38. Chen, Y.; Bopda-Waffo, A.; Basu, A.; Krishnan, R.; Silberstein, E.; Taylor, D.R.; Talele, T.T.; Arora, P.; Kaushik-Basu, N. Characterization of aurintricarboxylic acid as a potent hepatitis C virus replicase inhibitor. Antivir. Chem. Chemother., 2009, 20, 19-36.
39. Kaushik-Basu, N.; Bopda-Waffo, A.; Talele, T.T.; Basu, A.; Chen, Y.; Kücücgücel, Ş.G. 4-Thiazolidinones: a novel class of hepatitis C virus NS5B polymerase inhibitors. Front. Biosci., 2008, 13, 3857-3868.
40. Kaushik-Basu, N.; Bopda-Waffo, A.; Talele, T.T.; Basu, A.; Costa, P.R.; da Silva, A.J.; Sarafianos, S.G.; Noel, F. Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors. Nucleic Acids Res., 2008, 36, 1482-1496.
41. Kim, K.; Kim, K.H.; Kim, H.Y.; Cho, H.K.; Sakamoto, N.; Cheong, J. Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. FEBS Lett., 2010, 584, 707- 712.
42. Nichols, D.B.; Fournet, G.; Gurukumar, K.R.; Basu, A.; Lee, J-C.; Sakamoto, N.; Kozielski, F.; Musmuca, I.; Joseph, B.; Ragno, R.; Kaushik-Basu, N. Inhibition of Hepatitis C Virus NS5B Polymerase by S-Trityl-L-Cysteine Derivatives. Eur. J. Med. Chem.,2012, 49, 191-199.
43. Mossman, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 1983, 65, 55-63.
44. Woerdenbag, H.J.; Moskal, T.A.; Pras, N.; Malingrüc T.M.; El- Feraly, F.S.; Kampinga, H.H.; Konings, A.W. Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells. J. Nat. Prod., 1993, 56, 849-856.